 |
|
|
 |
|
Rationale:
- Neuroimaging scans in the form of CT or MRI can show changes consistent with cell death in basal ganglia and watershed areas,
which highly suggest severe CO intoxication.
|
|
Evidence:
- Case series of CO-poisoned patients studied with CT in 19 patients (35) showed abnormal low-density lesions in the basal ganglia in 10 patients, whereas 2 of 2 patients studied with MRI (36) showed edema in the basal ganglia.
- In a case series of 40 patients, normal CT scans correlated with complete recovery after HBOT, whereas any abnormalities predicted
incomplete neurologic recovery or death (37).
|
|
Comments:
- Neuropsychologic testing should not be used as a standard diagnostic tool for CO toxicity, except as a research tool or in
centers with psychologists experienced in the diagnosis of CO poisoning.
- Although neuropsychologic testing results were abnormal in a series of 8 patients (38), it is not specific for CO poisoning and did not predict benefit of HBOT (39) in a series of 48 patients.
|
| FAQs |
|
|
|
Jeffrey T. Chapman, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for
continuing medical education grand rounds and lectures given.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|